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Certain non-fastidious Gram-negative bacilli, notably Enterobacter cloacae,
although classified as susceptible by usual in-vitro susceptibility testing, often
become resistant in patients treated with newer /J-lactam antibiotics. Here various
in-vitro tests were carried out together with an animal model allowing the quantifi-
cation of resistance that emerges after short term therapy. Mice were challenged
(10* cfu plus talcum) intraperitoneally with one each of four strains of Ent. cloacae.
Two hours later, a single /Mactam dose was administered subcutancously. The
following day, the peritoneal bacterial population was analysed by using antibiotic-
containing gradient plates. Development of resistance after therapy varied according
to the compound considered. Imipenem (SOmg/kg) produced no resistance, and
piperacillin (200mg/kg) only a few, while resistance occurred frequently after
therapy with aztreonam (50 mg/kg), ceftazidime (50 mg/kg), cefotaxime (50 mg/kg)
and cefpirome (50 mg/kg). MICs increased by at least 16-fold when resistance
developed. No simple correlations were found between these in-vivo results and
initial MICs, killing kinetics, frequency of resistant variants within the bacterial
populations before therapy, initial MIC of these variants or antibiotic concentra-
tions assayed in peritoneal fluid 60 min after dosing. The most reliable predictive in-
vitro test appeared to be the determination of resistance emerging in broth
containing at least 16 times the MIC of the antibiotic tested. Such a test is unlikely
to be used on a routine basis. When a /Mactam compound seems appropriate for
treating an Enterobacter infection, it may be advisable to avoid drugs that are prone
prone to produce resistance in experimental or clinical infections, whatever the
results of conventional in-vitro susceptibility tests.
Introduction
During recent years, the development of bacterial resistance after therapy with newer
0-lactam antibiotics has been a concern (Sanders & Sanders, 1985). Bacterial species
possessing this capacity include mainly non-fastidious Gram-negative aerobic bacilli,
notably Enterobacter cloacae. These organisms are often classified as susceptible with
the conventional susceptibility testing, causing 'very major' errors (Sanders, 1984)
potentially harmful for the patients. In our laboratory, we have developed a murine
model to detect and quantify resistance emerging after short-time therapy (Pechere et
al., 1986). In this model, we have shown that resistance could occur after a single
administration of a /Mactam compound but the rate of resistance varied according to
the compound considered (Marchou et al., 19876). Ceftriaxone, a third generation
cephalosporin, appeared to be the most prone to select resistance in Ent. cloacae
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infections, followed by carumonam, a monobactam. No resistance occurred after
therapy with either cefepime (previously BMY28142) a newer cephalosporin, or
SCH 34343, a new penem. Since these observations may help the clinician, we carried
out experiments with six other currently used /J-lactam compounds and four strains of
Ent. cloacae. The in-vivo results were matched with various in-vitro tests carried out
with the same strains and the same antibiotics.
Materials and methods
Antibiotics, strains and culture media
Aztreonam, ceftazidime, cefotaxime, cefpirome, imipenem and piperacillin were kindly
supplied by their respective manufacturers in the form of powder of known potency,
from which fresh working solutions were prepared immediately before use. Four
clinical isolates of Ent. cloacae, strains 218, 219, 895 and 908, previously described by
Marchou et al. (1987a) were studied. Strains were maintained in skim milk and stored
at — 70°C. At the start of the study, the strains were thawed and plated on blood agar
to check purity. Mueller-Hinton broth and agar (Oxoid Ltd, Basingstoke, Hampshire,
England) were used for all precultures, in-vitro tests, colony counts and antibiotic-
containing gradient plates. The incubation temperature was 35°C.
Susceptibility testing
Antimicrobial activity was determined by two methods. The first was a microdilution
technique for determination of MICs (Thornsberry et al., 1983). The second uses
antibiotic-containing gradient plates (Bryson & Szybalski, 1952) as described
previously (Michea-Hamzehpour et al., 1987). This method allowed the definition of
two levels of antibiotic activity. The first level was read at the boundary concentration.
The boundary is the relatively sharp limit separating the confluent growth at lower
antibiotic concentrations from the zone of higher antibiotic concentrations, where only
single colonies grow. The second level of antibiotic activity, called the no-growth
concentration in this article, was the minimal concentration inhibiting all visible
growth.
Killing effect and emergence of resistance in vitro
Strains of Ent. cloacae were grown overnight in broth and inocula were diluted in order
to provide approximately 3xl07cfu/ml and added to broth (final volume 5 ml)
containing 16 times the MIC of the drug to be tested. Cells were subcultured
immediately and after 6 and 12 h of incubation. For viable counts, a portion (01 ml)
was sampled from each vial, diluted serially into 0-9% NaCl and plated on antibiotic-
free agar. Colonies were enumerated after 24 h of incubation. For determination of
boundary concentrations, another portion (0-1 ml) of bacterial culture was transferred
to antibiotic-free broth and incubated overnight. Then 0-1 ml of this culture was spread
uniformly over the antibiotic-containing gradient plates. After incubation for 24 h,
bacterial growth was examined as described in the susceptibility testing section.
Frequency of resistant variants
Portions (0-1 ml) of an overnight broth culture were uniformly spread on antibiotic-free
agar (after proper dilution) and antibiotic-containing agar (undiluted inoculum).
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Antibiotic concentrations were four and eight times the corresponding MICs. Colonies
were counted after 24 h of incubation.
Animal model
Swiss ICR female mice, weighing 20 to 30 g, were conditioned for one week after
receipt from the breeders and kept in conventional cages with free access to water and
antibiotic-free chow. Inoculum was prepared from an overnight broth culture and
diluted with 0-9% NaCl. One ml of this overnight diluted culture containing approxi-
mately 10s cfu and 125 mg of sterile talcum (magnesium hydropolysilicate) was injected
intraperitoneally to establish peritonitis. Talcum was used as a foreign body in order to
obtain lethal sepsis in all control mice (Pechere et al., 1986). Two hours after bacterial
challenge, a single dose of antibiotic was administered subcutaneously. Twenty-two
hours later, mice were killed by hyperanaesthesia and peritoneal fluid was sampled and
plated after appropriate dilutions on antibiotic-free agar for colony counts, whereas the
rest of the sample was placed in antibiotic-free broth to allow overnight growth for
further susceptibility testing. Data were compared from treated and untreated control
animals. A significant shift towards resistance was defined as an increase of the
boundary concentration by at least four-fold.
Antibiotic assay
Drug concentrations in peritoneal fluid of uninfected mice were determined by a
microbiological assay, as previously described (Michea-Hamzehpour et al., 1986).
Results
Susceptibility testing before therapy
Before therapeutic exposure, the four strains of Ent. cloacae were susceptible to the
antibiotics tested (Table I). On a concentration basis aztreonam and cefpirome were the
most potent drugs. All strains exhibited a similar susceptibility profile to /Mactam
antibiotics. MICs as determined by microdilution and boundary concentrations as
assessed on antibiotic-containing gradient plates were equivalent within one dilution.
Single colonies grew beyond the boundary concentration on gradient agar for all drugs
except imipenem. The no-growth concentrations varied from strain to strain, isolate
895 showing the highest values.
Frequency of resistant variants
Actual inoculum size in these experiments was (mean±s.D.) 115±0-33 x lO'cfu.
Similar growth (0-46-3-20 x 106 colonies) was observed on plates containing aztreonam,
ceftazidime, cefotaxime or piperaciUin (Table I). Resistant variants were less frequent
on cefpirome agar, while imipenem agar yielded no growth. Plates seeded with strain
895 showed higher frequency of variants with all antibiotics except on ceftazidime agar,
where strain 219 appeared to contain more variants. The MICs of resistant variants
were remarkably stable after several subpassages in antibiotic-free agar or broth.
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Tabk L Susceptibility testing and frequency of resistant variants of Ent. cloacae parent strains
Drug
Aztreonam
Ceftazidime
Cefotaxnne
Cefpirome
Lmipcnem
Pipcracillin
Strain
218
908
219
895
218
908
219
895
218
908
219
895
218
908
219
895
218
908
219
895
218
908
219
895
Concentration
microdilution
MIC
003
0-O3
003
004
0-25
0-25
0-25
0-25
0125
0-25
0-25
0-50
006
003
006
006
0-5
0-5
0-5
0-75
2
1
2
4
(mg/1) determined by
antibiotic
boundary
0125
006
0-06
006
0-50
0-50
0-25
0-50
0-50
0-25
0-25
0-50
006
0-03
006
0-06
0-8
0-8
0-5
10
4
2
4
8
gradient
no-growth
8
12
32
48
32
8
64
%
64
32
96
128
2
2
4
8
0-8
0-8
0-5
10
140
75
192
256
Frequency
resistant
4 x M I C
1-46
110
0-61
2-70
114
1-09
2-83
1-40
1-25
104
0-81
3-20
013
0-80
0-33
1-80
<001
<001
<001
<001
0-95
0-99
0-47
1-23
(xlO-*)
variants
8 x M I C
1-09
0-95
0-52
2-40
0-78
0-80
2-67
1-20
0-97
0-83
0-74
2-80
002
010
0-12
071
<0-01
<001
<001
<001
0-65
0-97
0-46
1-03
In-vitro killing studies
Actual inoculum size was (mean±s.D.) 3-3 ±0-89 x 107cfu/ml. Viable counts decreased
by more than 2 logs under all test conditions (Table II). Imipenem was the most
bactericidal compound (3-8-4-5 Iog10/ml decrease after 6 h, compared to 2-9-3-4 in the
case of the five other antibiotics). Generally less viable cells were found after 12 h
(except in four cases). After 24 h of incubation, regrowth was observed in all cases (data
not shown).
Emergence of resistance in vitro
Increase in the boundary concentration was measured after 12 h of drug exposure in
the vials used for killing studies. Subcultures were made into antibiotic-free broth, then
on antibiotic-containing gradients. The decrease in susceptibilities was impressive with
aztreonam, ceftazidime, cefotaxime and cefpirome, and notably less striking with
piperacillin (Table II). No resistance developed when imipenem was tested.
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Table n . Killing studies and susceptibility testing by antibiotic-containing
gradient agar of Ent. cloacae parent strains (inoculum 3-3 ± 0-89 x 107 cfu/ml)
after 6 and 12 h of incubation in Mueller-Hinton broth containing 16 x MIC
of each of six antibiotics
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Antibiotic
Aztreonam
Ceftazidime
Cefotaxime
Cefpirome
I mi pen em
Piperacillin
Strain
218
908
219
895
218
908
219
895
218
908
219
895
218
908
219
895
218
908
219
895
218
908
219
895
Logl0 cfu/ml
after
6h
2-85
2-32
3-38
2-97
3-00
305
2-85
2-50
3-01
3-45
4-28
2-95
2-86
3-39
3-89
3-84
4-53
4-26
4-39
3-83
314
2-99
2-71
306
decrease
12 h
3-22
2-83
319
4-08
317
414
3-88
416
3-07
2-53
2-25
4-58
3-46
3-51
4-53
3-55
615
4-97
5-78
4-55
3-72
3-83
2-96
3-74
Fold increase of
boundary
concentration after
12h
500
600
>6O0
>600
120
200
>600
>600
200
500
>600
>600
32
>600
>600
>600
1
1
1
1
50
40
75
35
Animal studies
Thirty-six infected, but untreated, mice were used as controls. Severe peritonitis was
observed in all cases. At autopsy, the peritoneal fluid was purulent and contained
3-49 ± 1-19 x 10'° cfu/ml. Since the number of peritoneal bacteria at the time of death
clearly surpassed the injected inoculum (1 -51 ±0-46 x 10s cfu/ml), an actual infection
occurred in all cases.
One hundred forty four infected mice were treated. Therapeutic activity was assessed
by comparing the number of peritoneal viable counts in control and treated animals
(Table III). All treatments produced antibacterial effect, which varied according to the
drug. The most efficient antibiotics were aztreonam, ceftazidime, cefpirome and
imipenem. Cefotaxime and above all, piperacillin produced less killing (P < 0-05)
compared to the four others by student's t test). Development of resistance after
therapy varied according to the compound considered. Imipenem produced no resist-
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Table III. Bacterial population analysis of peritoneal fluid after a single dose
therapy in mice challenged with Ent. cloacae (inoculum: 1-5 ± 0-46 x 10* cfu).
Six mice were used in each row
Treatment
(mg/kg)
Aztreonam
Ceftazidime
Cefotaxime
Cefpirome
Imipenem
Piperacillin
Strain
218
908
219
895
218
908
219
895
218
908
219
895
218
908
219
895
218
908
219
895
218
908
219
895
Log|0 cfu decrease*
after therapy
(mean±S.D.)
2-5 ±1-9
2 0 ± 0-6
3-4 ± 2-2
1-3 ±0-6
2-3 ±1-3
4-1 ± 1-7
2-9 ±1-5
4-2 ±1-8
10 ±0-8
l-6± 1-5
1-4 ±1-2
0-6 ± 0-4
2-2 ±1-4
2-5 ±0-8
1-2 ±0-7
l-4± 1-5
1-9 ±0-9
2-3 ±1-3
2-9 ± 1 1
2-3 ± 1 1
0-8 ± 0-6
0-3 ± 0 1
0-2 ± 0 1
0-3 ± 0 1
Number of mice with acquired
resistance (fold increase of
boundary concentration)
1(250)
4(25O-«00)
3(>5O0)
2(500)
3(125-200)
2(250)
5(250-640)
4(500)
6(125-250)
6(250-500)
5(400-1000)
6(300-500)
5(16-250)
4(64-250)
3(32-140)
4(64-500)
0
0
0
0
1(32)
0
1(32)
0
"As determined in peritoneal fluid after companion with control animal*.
ance, and piperacillin only a little, while more resistance occurred frequently after
therapy with the four other drugs. Analysis by the chi square test applied to these
results (with three degrees of freedom to take into account the data of each strain
separately) showed that the difference between imipenem and piperacillin on the one
hand, and the four other drugs on the other hand, was significant (P < 0-05), but not
the differences between aztreonam, cefotaxime, ceftazidime and cefpirome or between
imipenem and piperacillin.
Antibiotic assays
Antibiotic concentrations in peritoneal fluid of non-infected mice 60 min after subcuta-
neous administration are presented in Table FV. All these concentrations were well
above the initial MICs of the organisms causing the infection.
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Table IV. Antibiotic concentration in peritoneal fluid of
non-infected mice 60min after /Mactam subcutaneous
administration
Antibiotic
Aztreonam
Ceftazidime
Cefotaxime
Cefpirome
Imipenem
Piperacillin
dosage
(mg/kg)
50
50
50
50
50
200
Antibiotic concentration
in peritoneal fluid'
(mg/1)
36-4
57-8
34-4
35-7
12-3
51-8
'Mean of three determinations.
Discussion
The present study confirmed that development of resistance depended on the /Mactam
administered to the animal. Imipenem and piperacillin, as cefepime (ex BMY 28142)
and SCH 34343 in previous studies (Marchou et al., 19876) were less prone to produce
resistance in Ent. cloacae infection than the other compounds tested. The mechanisms
by which Enterobacter spp. can escape the lethal effects of potent antibiotics such as
third-generation cephalosporins is complex. Ent. cloacae possesses the ampC gene
(Lindberg & Normark, 1988) encoding for /Mactamases falling into class I of the
Richmond & Sykes' classification (Richmond & Sykes, 1973). The most convincing
indication that /Mactamases are associated with resistance was provided by transfer of
the chromosomal bla gene from a stably derepressed mutant of Ent. cloacae into
Escherichia coli, leading to acquisition of /Mactam resistance by the recipient Esch. coli
(Seeberg et al., 1983). Enterobacter populations are heterogenous with regard to /?-
lactamase production. The wild type cells produce basal low levels of enzymes, which
can be greatly increased by induction (Lindberg & Normark, 1987). Linked to the
inducibility is the ability to undergo mutation to high level constitutive /Mactamase
production. Such mutants occurred at high frequency (10~5 to 10"7) and appeared to
be highly resistant to penicillins (including piperacillin), and the cephalosporins tested;
they exhibited decreased susceptibility to aztreonam, but remained susceptible to
imipenem. Whether the resistance is caused by inducible wild type cells or by constitu-
tive hyperproducer mutants has been a matter of controversy, but several lines of
evidence favour the second hypothesis (Livermore & Young, 1987; Marchou et al.,
1987a). Consistently /Mactamase production by all four Ent. cloacae strains used in our
study was inducible (Marchou et al., 1987a), and that did not correlate the emergence
of resistance in the mice. However, limited penetration of the antibiotic into the
bacterial cell is an important consideration for the understanding of resistance. Several
studies have shown that relative impermeability of the outer membrane acts synergisti-
cally with enzymatic inactivation to produce resistance (Marchou et al., 1987a; Sawai,
Yamaguchi & Hiruma, 1988). In our study, this interactive system probably accounted
for the performance of imipenem, whose compact molecular structure (MW299)
endowed it with the highest penetration rate among all /Mactams tested in reconstituted
proteoliposomes with porins of Esch. coli (Yoshimura & Nikaido, 1985) or in intact
cells of Esch. coli, Ent. cloacae and Citrobacter frewdii (Hashizume, Yamaguchi &
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Sawai, 1986). The inability of piperacillin to select resistance in the mouse does not fit
the model however, as this drug is rapidly hydrolysed by Ent. cloacae /?-lactamase
(unpublished personal results) and exhibited a slow relative permeability rate (Yochi-
mura & Nikaido, 1985).
The question of resistance developing during therapy is even more knotty since,
besides bacterial characteristics, pharmacokinetics and host factors also contribute.
The prediction of successful therapy which is the major issue of susceptibility testing
appears here specially difficult. It has been well recognized (Sanders, 1984) that
conventional tests fail to detect these types of resistance. MICs were consistently poor
predictors of response of infection in-vivo. The MICs of the resistant variants, as
determined by the no-growth concentrations, together with the antibiotic concentra-
tions obtained in the peritoneal fluid, were thought to be associated with further
emergence of resistance in the mouse (Marchou el al., 19876). Unfortunately this
assumption did not hold in the present study, as eloquently illustrated by the pipera-
cillin and the cefpirome results (Tables I and III).
Also disappointing was the frequency of resistant variants. For instance, in
aztreonam experiments conducted with strains 219 and 895 respectively, the number of
colonies growing on agar plates containing four or eight times the MIC did not
correlate accurately with the murine trials.
In a study dealing with a few human cases of meningitis caused by Enterobacter and
Serratia spp. (Eng et al., 1987) the extent to which an isolate was killed by cefotaxime
or latamoxef in a 6-h in-vitro incubation showed good correlation with the clinical
outcome. However, once again, the present study cannot support this view, as
compounds showing similar killing effects against a specific strain did not necessarily
display different resistant rates in the animal.
Finally, the most reliable in-vitro test in this study was the determination of the
emergence of resistance in broth containing 16 times the MIC of the drug as shown in
Table II. Piperacillin and imipenem performed better, both in-vitro and in-vivo. One
must admit however that such a test, although easy to perform in a research laboratory,
would be difficult to carry out on a routine basis. On practical grounds, a pragmatic
attitude is probably relevant. When a /Mactam antibiotic seems indicated for treating
an Ent. cloacae infection recognized as such, it is probably advisable to select a
molecule which is less likely to produce resistance, as shown in the murine model.
Imipenem, piperacillin, as well as cefepime and SCH 34343 (Marchou et al., 19876)
belong to this list.
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